Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination
Saishravan Shyamsundar(University of Pennsylvania), David C. Fajgenbaum(University of Pennsylvania), Ariela Noy(Memorial Sloan Kettering Cancer Center), Dorry L. Segev(New York University), William A. Werbel(Johns Hopkins University), Sheila K. Pierson(University of Pittsburgh Medical Center), Mayan Teles(Johns Hopkins University), Corey Casper(University of Washington), Joshua D. Brandstadter(University of Pennsylvania), Frits van Rhee(Winthrop Rockefeller Foundation), Caoilfhionn M Connolly
Cited by 2
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
|JAMA|2021|536
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2016|452